Wordt geladen...
The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice
BACKGROUND & AIMS: In recent years, nonalcoholic steatohepatitis (NASH) has become a considerable healthcare burden worldwide. Pathogenesis of NASH is associated with type 2 diabetes mellitus (T2DM) and insulin resistance. However, a specific drug to treat NASH is lacking. We investigated the ef...
Bewaard in:
| Gepubliceerd in: | PLoS One |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4701474/ https://ncbi.nlm.nih.gov/pubmed/26731267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0146337 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|